Title | Type | SJR | H index | Total Docs. (2017) | Total Docs. (3years) | Total Refs. (2017) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2017) | %Female (2017) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Pharmaceutical Design | journal | 0.883 Q2 | 183 | 620 | 1828 | 74679 | 5143 | 1667 | 2.66 | 120.45 | 41.54 | |
2 | Current Medicinal Chemistry | journal | 1.015 Q2 | 202 | 284 | 873 | 35541 | 2862 | 815 | 3.32 | 125.14 | 42.59 | |
3 | Current Topics in Medicinal Chemistry | journal | 0.885 Q2 | 133 | 262 | 747 | 27685 | 2168 | 649 | 3.09 | 105.67 | 38.41 | |
4 | Current Drug Targets | journal | 0.906 Q2 | 119 | 140 | 536 | 14215 | 1303 | 481 | 2.13 | 101.54 | 41.85 | |
5 | CNS and Neurological Disorders - Drug Targets | journal | 0.863 Q2 | 96 | 125 | 504 | 9747 | 1140 | 436 | 1.83 | 77.98 | 45.17 | |
6 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.674 Q2 | 108 | 174 | 488 | 9129 | 1081 | 454 | 2.02 | 52.47 | 43.09 | |
7 | Current Neuropharmacology | journal | 1.210 Q1 | 103 | 83 | 241 | 9247 | 912 | 213 | 3.28 | 111.41 | 40.82 | |
8 | Mini-Reviews in Medicinal Chemistry | journal | 0.567 Q2 | 107 | 115 | 399 | 12053 | 863 | 366 | 2.08 | 104.81 | 48.82 | |
9 | Current Drug Delivery | journal | 0.443 Q2 | 72 | 97 | 323 | 5202 | 590 | 307 | 1.67 | 53.63 | 42.86 | |
10 | Current Cancer Drug Targets | journal | 0.951 Q1 | 103 | 69 | 223 | 6431 | 569 | 204 | 2.18 | 93.20 | 44.49 | |
11 | Current Vascular Pharmacology | journal | 0.715 Q2 | 69 | 68 | 292 | 5333 | 555 | 233 | 1.71 | 78.43 | 41.22 | |
12 | Medicinal Chemistry | journal | 0.372 Q3 | 50 | 80 | 270 | 4278 | 404 | 261 | 1.69 | 53.48 | 38.85 | |
13 | Current Nanoscience | journal | 0.292 Q2 | 52 | 75 | 346 | 3601 | 381 | 322 | 1.21 | 48.01 | 33.03 | |
14 | Letters in Drug Design and Discovery | journal | 0.247 Q3 | 37 | 149 | 371 | 5398 | 362 | 368 | 0.89 | 36.23 | 43.22 | |
15 | Current Gene Therapy | journal | 0.951 Q1 | 80 | 44 | 140 | 4205 | 309 | 131 | 2.13 | 95.57 | 41.06 | |
16 | Combinatorial Chemistry and High Throughput Screening | journal | 0.346 Q3 | 70 | 95 | 288 | 4560 | 304 | 253 | 1.10 | 48.00 | 35.29 | |
17 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.760 Q2 | 52 | 27 | 83 | 3115 | 216 | 78 | 2.43 | 115.37 | 41.11 | |
18 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 38 | 113 | 1897 | 198 | 102 | 1.60 | 49.92 | 38.69 | ||
19 | Reviews on Recent Clinical Trials | journal | 0.498 Q3 | 35 | 43 | 132 | 1860 | 196 | 117 | 0.95 | 43.26 | 41.82 | |
20 | Current Molecular Pharmacology | journal | 0.996 Q1 | 49 | 27 | 90 | 2153 | 168 | 75 | 1.90 | 79.74 | 28.00 | |
21 | Current Drug Safety | journal | 0.348 Q3 | 41 | 32 | 134 | 959 | 144 | 123 | 1.10 | 29.97 | 49.31 | |
22 | Current Drug Discovery Technologies | journal | 0.449 Q3 | 49 | 23 | 75 | 1136 | 113 | 73 | 1.59 | 49.39 | 32.67 | |
23 | Current Pharmaceutical Analysis | journal | 0.224 Q3 | 27 | 70 | 143 | 1998 | 106 | 134 | 0.75 | 28.54 | 49.42 | |
24 | Current Computer-Aided Drug Design | journal | 0.259 Q3 | 32 | 33 | 116 | 1263 | 99 | 100 | 0.74 | 38.27 | 35.48 | |
25 | Recent Advances in Drug Delivery and Formulation | journal | 41 | 23 | 70 | 1273 | 98 | 67 | 1.14 | 55.35 | 45.45 | ||
26 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.513 Q3 | 45 | 28 | 71 | 1457 | 91 | 64 | 1.13 | 52.04 | 38.68 | |
27 | Current Radiopharmaceuticals | journal | 0.389 Q3 | 32 | 27 | 74 | 762 | 86 | 67 | 1.26 | 28.22 | 38.93 | |
28 | Infectious Disorders - Drug Targets | journal | 0.323 Q3 | 61 | 28 | 88 | 886 | 82 | 76 | 0.95 | 31.64 | 40.19 | |
29 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | journal | 0.369 Q3 | 28 | 8 | 58 | 478 | 80 | 54 | 1.11 | 59.75 | 41.38 | |
30 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 13 | 61 | 1038 | 78 | 57 | 1.26 | 79.85 | 44.74 | ||
31 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 14 | 63 | 610 | 73 | 52 | 1.26 | 43.57 | 32.56 | ||
32 | Current Bioactive Compounds | journal | 0.183 Q3 | 31 | 39 | 113 | 1610 | 70 | 101 | 0.62 | 41.28 | 39.87 | |
33 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.336 Q3 | 43 | 8 | 79 | 502 | 68 | 67 | 0.81 | 62.75 | 39.39 | |
34 | Recent Patents on CNS Drug Discovery | journal | 0.383 Q3 | 36 | 0 | 45 | 0 | 62 | 39 | 1.11 | 0.00 | 0.00 | |
35 | Drug Metabolism Letters | journal | 0.314 Q2 | 31 | 19 | 72 | 820 | 60 | 65 | 0.78 | 43.16 | 33.82 | |
36 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.189 Q4 | 27 | 15 | 72 | 675 | 50 | 65 | 0.48 | 45.00 | 49.25 | |
37 | Anti-Infective Agents | journal | 0.191 Q3 | 26 | 18 | 63 | 626 | 42 | 56 | 0.55 | 34.78 | 37.50 | |
38 | Current Enzyme Inhibition | journal | 0.197 Q4 | 19 | 21 | 56 | 1234 | 36 | 50 | 0.65 | 58.76 | 32.14 | |
39 | Current Drug Therapy | journal | 0.161 Q3 | 20 | 16 | 63 | 556 | 30 | 56 | 0.68 | 34.75 | 46.67 | |
40 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.167 Q4 | 17 | 15 | 62 | 690 | 16 | 53 | 0.16 | 46.00 | 35.29 | |
41 | Open Medicinal Chemistry Journal | journal | 0.281 Q2 | 23 | 15 | 11 | 649 | 10 | 11 | 0.71 | 43.27 | 43.28 | |
42 | Current Pharmacogenomics and Personalized Medicine | journal | 0.123 Q4 | 20 | 16 | 56 | 1195 | 7 | 52 | 0.05 | 74.69 | 58.33 | |
43 | Current Clinical Pharmacology | journal | 0.550 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
44 | Open Drug Discovery Journal | journal | 0.123 Q4 | 10 | 0 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | |
45 | Recent Patents on Drug Delivery and Formulation | journal | 0.373 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
46 | Recent Patents on Inflammation and Allergy Drug Discovery | journal | 0.314 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®